Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:mythological_figure
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:mythological_figure
|
| gptkbp:agent |
Bacillus anthracis spores
|
| gptkbp:associated_with |
agriculture
bioterrorism |
| gptkbp:caused_by |
gptkb:Bacillus_anthracis
|
| gptkbp:characteristics |
edema
eschar formation painless ulcer |
| gptkbp:complications |
gptkb:cemetery
meningitis sepsis |
| gptkbp:disease_resistance |
gptkb:ciprofloxacin
gptkb:penicillin doxycycline |
| gptkbp:distribution |
worldwide
|
| gptkbp:duration |
7 to 14 days
|
| gptkbp:end_of_life |
low with treatment
high without treatment |
| gptkbp:first_described_by |
gptkb:19th_century
|
| gptkbp:healthcare |
gptkb:battle
|
| gptkbp:historical_significance |
used in biological warfare
|
| https://www.w3.org/2000/01/rdf-schema#label |
cutaneous anthrax
|
| gptkbp:incubation_period |
1 to 12 days
|
| gptkbp:is_often_used_in |
gptkb:Farmers_Market
veterinarians laboratory workers |
| gptkbp:is_protected_by |
vaccination
wearing protective clothing proper disposal of animal products |
| gptkbp:is_vulnerable_to |
gptkb:battle
|
| gptkbp:public_awareness |
education on prevention measures
important for at-risk populations |
| gptkbp:research_focus |
treatment protocols
vaccine development pathogenesis studies |
| gptkbp:risk_factor |
handling animal products
working with infected livestock |
| gptkbp:social_responsibility |
gptkb:2001_anthrax_attacks_in_the_US
laboratory tests clinical examination PCR testing culture of lesions historical outbreaks in Europe outbreaks in Africa outbreaks in Asia |
| gptkbp:symptoms |
fatigue
headache fever swelling chills skin lesions itching muscle aches black necrotic ulcer |
| gptkbp:transmission |
direct contact
contact with infected animals |
| gptkbp:treatment |
antibiotics
generally favorable with early treatment |